BioAge Labs, Inc.
BIOA
$18.19
$0.030.17%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -26.58% | -13.35% | -6.84% | -27.14% | -8.03% |
| Total Depreciation and Amortization | 39.77% | 27.54% | 18.63% | 5.26% | 5.56% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 25.27% | 28.49% | -15.78% | -35.89% | -53.90% |
| Change in Net Operating Assets | -223.32% | -205.83% | 158.72% | 472.39% | 254.31% |
| Cash from Operations | -65.96% | -58.43% | -6.61% | -20.29% | -23.66% |
| Capital Expenditure | 59.72% | -96.45% | -86.18% | -583.58% | -410.97% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 17.92% | -- | -- | -- | -- |
| Cash from Investing | 18.34% | -25,915.30% | -23,668.82% | -70,019.40% | -50,450.97% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | -9.09% | -50.00% | -140.00% |
| Issuance of Common Stock | -35.26% | -91.96% | -85.79% | 51,608.16% | 3,174,900.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -100.00% | -100.00% | -100.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 73.48% | 92.09% | 66.31% | -73.79% | -711.41% |
| Cash from Financing | -35.43% | -96.99% | -94.27% | 29.18% | 17.97% |
| Foreign Exchange rate Adjustments | -304.00% | -207.41% | 157.02% | 175.00% | 61.29% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -119.59% | -150.23% | -139.64% | -47.51% | -41.17% |